ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Targets high-growth eye care expansion push
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Subscribe To Our Newsletter & Stay Updated